Everolimus improves progression-free survival for patients with advanced, nonfunctional neuroendocrine tumors of the lung, gastrointestinal tract
MD Anderson led research in field, from small investigator-initiated studies to international confirmatory trials
MD Anderson News Release 09/26/2015
In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced, nonfunctional neuroendocrine tumors (NET) of the lung and gastrointestinal...
Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients
CheckMate-025 study led by The University of Texas MD Anderson Cancer Center portends paradigm change in standard of care treatment...
MD Anderson study identifies leukemia tumor suppressor
Protein-coding gene hnRNP K may be culprit in acute myeloid leukemia
MD Anderson News Release 09/24/2015
A protein-coding...
A Conversation With a Living Legend® returns to San Antonio to honor Emmitt Smith
Football legend teams up with MD Anderson to support cancer research
MD Anderson News Release 09/22/2015
The University of Texas MD Anderson Cancer Center heads to San Antonio Oct. 13 for the sixth annual A Conversation With a Living Legend® honoring Pro Football Hall of Fame member and “Dancing with the Stars” champion Emmitt Smith.
The luncheon and program will be held at the Marriott Rivercenter, 101...
MD Anderson, Cayman Chemical, and Fannin Innovation Studio form therapeutics company
ACF Pharmaceuticals to explore the potential of novel, small molecule anti-cancer agents
MD Anderson News Release 09/15/2015
...
MD Anderson immunologist Jim Allison wins Lasker-DeBakey Award
Cancer immunotherapy pioneer awarded prestigious U.S. medical research honor
MD Anderson News Release 09/08/2015
For inventing...
MD Anderson and Cellectis announce pre-clinical and clinical alliance in cancer immunotherapy
MD Anderson News Release 09/03/2015
Cellectis, the gene editing company employing proprietary technologies to develop best-in-class...
MD Anderson brings Making Cancer History® seminar to Atlanta
Free event offers information on the latest cancer treatment and prevention strategies
MD Anderson News Release 09/03/2015...
MD Anderson to honor Houstonians for their efforts to end cancer
River Oaks Country Club event to pay tribute to Houston community
MD Anderson News Release 09/02/2015
The University...
Michelle Barton receives Rogers Award for Excellence in Education
Esteemed educator strives to ‘put the students first’
MD Anderson News Release 09/01/2015
Michelle Barton, Ph.D., professor...